Insider Selling: Illumina CEO Unloads 30,000 Shares of Stock (ILMN)
Illumina (NASDAQ:ILMN) CEO Jay Flatley unloaded 30,000 shares of Illumina stock on the open market in a transaction dated Thursday, January 9th. The stock was sold at an average price of $114.77, for a total transaction of $3,443,100.00. Following the transaction, the chief executive officer now directly owns 399,509 shares in the company, valued at approximately $45,851,648. The transaction was disclosed in a filing with the SEC, which is available at this link.
A number of research firms have recently commented on ILMN. Analysts at Cowen and Company raised their price target on shares of Illumina to $125.00 in a research note to investors on Friday, December 20th. Separately, analysts at Mizuho raised their price target on shares of Illumina from $100.00 to $125.00 in a research note to investors on Thursday, December 19th. They now have a “buy” rating on the stock. Finally, analysts at JMP Securities initiated coverage on shares of Illumina in a research note to investors on Wednesday, December 18th. They set an “outperform” rating and a $125.00 price target on the stock. Seven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $92.27.
Illumina (NASDAQ:ILMN) traded up 1.63% during mid-day trading on Friday, hitting $116.67. The stock had a trading volume of 1,429,893 shares. Illumina has a one year low of $48.00 and a one year high of $117.50. The stock’s 50-day moving average is $104.4 and its 200-day moving average is $87.35. The company has a market cap of $14.747 billion and a price-to-earnings ratio of 136.99.
Illumina (NASDAQ:ILMN) last announced its earnings results on Monday, October 21st. The company reported $0.45 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.40 by $0.05. The company had revenue of $357.00 million for the quarter, compared to the consensus estimate of $343.42 million. During the same quarter in the prior year, the company posted $0.41 earnings per share. The company’s quarterly revenue was up 24.9% on a year-over-year basis. On average, analysts predict that Illumina will post $1.78 earnings per share for the current fiscal year.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.